Therapeutic Areas: Orthopedics & Spine
Engineering a Future Without Limits
Orthopedic trials have unique challenges, including design issues, sham controls, sample size, and the need for patient-centered outcomes.
As a sponsor, you need a fast, efficient, and focused approach for your orthopedic or spine medical device journey. Rest assured you’re in good hands when you choose Proxima as your development partner.
As a sponsor, you need a fast, efficient, and focused approach for your orthopedic or spine medical device journey. Rest assured you’re in good hands when you choose Proxima as your development partner.
Our clinical and regulatory management strategy focuses on agility, efficiency, speed, and a deep understanding of the orthopedic and spine space.
Whether your trial is in support of a PMA, 510(k), or post market surveillance, we understand the challenges of conducting successful medical device trials.
Orthopedics & Spine Experience
Support from start to finish. Proxima designs your trial endpoints to address the most pressing questions about your device's benefits early on.
Today’s regulatory requirements have placed more responsibility on sponsors to demonstrate clinical benefit through the safety and effectiveness results obtained from clinical trials.
Our team of experts will help you design trials that deliver the results you need, while also providing valuable insight across a wide range of modalities that require clinical trial and payor and provider evaluations.
Orthopedics Experience:
Hip Repair and Replacement
Shoulder Repair
Knee Repair and Replacement
Osteoarthritis
Osteoarthritis
Peripheral Joint Repair
Spine Experience
Trauma
Spine Experience:
Scoliosis
Compression Fracture
Spinal Fusion
Spinal Stenosis
Degenerative Disc Disease
Endpoint Experience:
Fusion Rates and Quality
(EQ-5D, SF-12, SF-36, VAS, HHS, KOOS, WOMAC)
(EQ-5D, SF-12, SF-36, VAS, HHS, KOOS, WOMAC)
Endpoint Adjudication Committees
HRQOL
Health Economics
RCT
(Power Calculations, Randomization Ratio, Blinding, Cohort Arms, Choice of Control Procedure, and Rate of Crossover, Dropout, and Missing Data)
(Power Calculations, Randomization Ratio, Blinding, Cohort Arms, Choice of Control Procedure, and Rate of Crossover, Dropout, and Missing Data)
Outcome Measures
(Time Points, Primary Composite Endpoint, Secondary Endpoints, Surrogate Radiographic Endpoints, Choice of Clinical Instruments, and Time of Final Follow-Up)
(Time Points, Primary Composite Endpoint, Secondary Endpoints, Surrogate Radiographic Endpoints, Choice of Clinical Instruments, and Time of Final Follow-Up)
Frequently Asked Question
Could the software change significantly affect clinical functionality or performance specifications that are directly associated with the intended use of the device?
Learn MoreGlossary
21 CFR 812
Learn MoreLatest INsight
Project MedTech: The Overlap of Regulatory Strategy And Business Strategy with Isabella Schmitt
Learn MoreLatest Video
Top 5 Considerations When Selecting a CRO for MedTech or Biotech Companies
Learn MoreTap into our wide rage of orthopedic and spine product experience,
and get a leg up on your clinical journey.
Engage with An orthopedic & Spine expert